Patents by Inventor Joel A. Saydoff

Joel A. Saydoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5'-O-Phenylacetyluridine and therapeutic use
    Publication number: 20230416292
    Abstract: 5?-O-Phenylacetyluridine effectively delivers both phenylacetate and uridine to a subject. It can be used to treat hepatic encephalopathy and genetic disorders of the hepatic nitrogen cycle.
    Type: Application
    Filed: November 30, 2021
    Publication date: December 28, 2023
    Inventors: ROLANDO ALEJANDRO GARCIA GARCIA, Joel A. SAYDOFF, David Michael SIMPSON, Reid Warren VON BORSTEL
  • Stem cell mobilization and tissue repair and regeneration
    Patent number: 9428552
    Abstract: Stem cells are mobilized from bone marrow by administering an amount of Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 2) or Phe-Ala-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 3) effective to mobilize the stem cells. This is useful for promoting bodily tissue regeneration in a patient in need of tissue regeneration treatment. Alternatively, the mobilized stem cells can be collected for transplant.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: August 30, 2016
    Assignee: Wellstat Therapeutics Corporation
    Inventors: Irena Tsyrlova, Fawn Petty, Reid W. von Borstel, Julian Reading, Jiong Pei, Joel Saydoff
  • Stem Cell Mobilization and Tissue Repair and Regeneration
    Publication number: 20160016997
    Abstract: Stem cells are mobilized from bone marrow by administering an amount of Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 2) or Phe-Ala-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Val-Ser-Asp-Lys-Pro (SEQ ID NO: 3) effective to mobilize the stem cells. This is useful for promoting bodily tissue regeneration in a patient in need of tissue regeneration treatment. Alternatively, the mobilized stem cells can be collected for transplant.
    Type: Application
    Filed: November 18, 2013
    Publication date: January 21, 2016
    Inventors: Irena Tsyrlova, Fawn Petty, Reid W. von Borstel, Julian Reading, Jiong Pei, Joel Saydoff
  • Compositions and methods for treatment of mitochondrial diseases
    Patent number: 7807654
    Abstract: Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: October 5, 2010
    Assignee: Wellstat Therapeutics Corporation
    Inventors: Reid W. Von Borstel, Joel A. Saydoff
  • Use of conantokins for producing analgesia or for neuoprotection
    Patent number: 6407204
    Abstract: A method for producing analgesia or for neuroprotection in a mammal comprising administering a therapeutically effective amount of a conantokin to the mammal.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: June 18, 2002
    Assignee: CytoTherapeutics, Inc.
    Inventor: Joel Saydoff
  • Compositions and methods for treatment of mitochondrial diseases
    Publication number: 20020049182
    Abstract: Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies.
    Type: Application
    Filed: August 16, 2001
    Publication date: April 25, 2002
    Inventors: Reid W. Von Borstel, Joel A. Saydoff
  • Use of conantokins for producing analgesia or for neuroprotection
    Patent number: 5844077
    Abstract: A method for producing analgesia or for neuroprotection in a mammal comprising administering a therapeutically effective amount of a conantokin to the mammal.
    Type: Grant
    Filed: April 28, 1997
    Date of Patent: December 1, 1998
    Assignee: CytoTherapeutics, Inc.
    Inventor: Joel Saydoff